Carmat has completed 50 implantations of Aeson hearts on patients waiting for a transplant in eight countries. Fourteen of them subsequently benefited from a transplant.
Francesco, a 46-year-old Italian suffering from end-stage biventricular heart failure, is one of the last patients to have benefited from it. The start-up continues its development and has just increased its capital. Its goal is to produce 500 devices pa pa in the next five years. In the coming months, ten more people should benefit from an Aeson heart.